Gaurav Kwatra

Prof. Gaurav Kwatra


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
MNMarta Nunes
Marta Nunes
SSSthembile Valencia Sibanda
Sthembile Valencia Sibanda
VBVicky Lynne Baillie
Vicky Lynne Baillie
GKGaurav Kwatra
Gaurav Kwatra
RARicardo Aguas
Ricardo Aguas
OGon behalf of the Wits VIDA HCW Study Group
on behalf of the Wits VIDA HCW Study Group
We investigated Omicron infections among healthcare workers (HCW) presenting with symptoms of SARS-CoV-2 infection and evaluated the protective effect of vaccination or prior infection. Between 24 November and 31 December 2021, HCW in Johannesburg, South Africa, were tested for SARS-CoV-2 infection by Nucleic Acid Amplification Test (NAAT). Blood samples collected either at the symptomatic visit or in the 3 months prior, were tested for spike protein immunoglobulin G (IgG). Overall, 433 symptomatic HCW were included in the analysis, with 190 (43.9%) having an Omicron infection; 69 (16.7%) were unvaccinated and 270 (62.4%) received a single dose of the Ad26.COV.2 vaccine. There was no difference in the odds of identifying Omicron between unvaccinated and Ad26.COV.2 vaccinated HCW (adjusted odds ratio (aOR) 0.81, 95% confidence interval (CI): 0.46, 1.43). One-hundred and fifty-four (35.3%) HCW had at least one SARS-CoV-2 NAAT-confirmed prior infection; these had lower odds of Omicron infection compared with those without past infection (aOR 0.55, 95%CI: 0.36, 0.84). Anti-spike IgG concentration of 1549 binding antibody unit/mL was suggestive of significant reduction in the risk of symptomatic Omicron infection. We found high reinfection and vaccine breakthrough infection rates with the Omicron variant among HCW. Prior infection and high anti-spike IgG concentration were protective against Omicron infection.

21 February 2023 in Viruses
Verified
Journal Article
Open access
PDF file
SMShabir Ahmed Madhi
Shabir Ahmed Madhi
GKGaurav Kwatra
Gaurav Kwatra
JMJonathan E. Myers
Jonathan E. Myers
WJWaasila Jassat
Waasila Jassat
NDNisha Dhar
Nisha Dhar
PMPortia Chipo Mutevedzi
Portia Chipo Mutevedzi
We conducted an epidemiologic survey to determine the seroprevalence of SARS-CoV-2 anti-nucleocapsid (anti-N) and anti-spike (anti-S) protein IgG from 1 March to 11 April 2022 after the BA.1-dominant wave had subsided in South Africa and prior to another wave dominated by the BA.4 and BA.5 (BA.4/BA.5) sub-lineages. We also analysed epidemiologic trends in Gauteng Province for cases, hospitalizations, recorded deaths, and excess deaths were evaluated from the inception of the pandemic through 17 November 2022. Despite only 26.7% (1995/7470) of individuals having received a COVID-19 vaccine, the overall seropositivity for SARS-CoV-2 was 90.9% (95% confidence interval (CI), 90.2 to 91.5) at the end of the BA.1 wave, and 64% (95% CI, 61.8 to 65.9) of individuals were infected during the BA.1-dominant wave. The SARS-CoV-2 infection fatality risk was 16.5–22.3 times lower in the BA.1-dominant wave compared with the pre-BA.1 waves for recorded deaths (0.02% vs. 0.33%) and estimated excess mortality (0.03% vs. 0.67%). Although there are ongoing cases of COVID-19 infections, hospitalization and death, there has not been any meaningful resurgence of COVID-19 since the BA.1-dominant wave despite only 37.8% coverage by at least a single dose of COVID-19 vaccine in Gauteng, South Africa.

30 September 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VGVicky Gent
Vicky Gent
YLYing-Jie Lu
Ying-Jie Lu
SLSindiswa Lukhele
Sindiswa Lukhele
NDNisha Dhar
Nisha Dhar
ZDZiyaad Dangor
Ziyaad Dangor
GKGaurav Kwatra
Gaurav Kwatra
Group B Streptococcus (GBS) is a major cause of pneumonia, sepsis, and meningitis in infants younger than 3 months of age. Furthermore, GBS infection in pregnant women is associated with stillbirths and pre-term delivery. It also causes disease in immunocompromised adults and the elderly, but the highest incidence of the disease occurs in neonates and young infants. At this time, there are no licensed vaccines against GBS. Complete GBS genome sequencing has helped identify genetically conserved and immunogenic proteins, which could serve as vaccine immunogens. In this study, in silico reverse vaccinology method were used to evaluate the prevalence and conservation of GBS proteins in invasive and colonizing isolates from South African infants and women, respectively. Furthermore, this study aimed to predict potential GBS vaccine targets by evaluating metrics such as antigenicity, physico-chemical properties, subcellular localization, secondary and tertiary structures, and epitope prediction and conservation. A total of 648 invasive and 603 colonizing GBS isolate sequences were screened against a panel of 89 candidate GBS proteins. Ten of the 89 proteins were highly genetically conserved in invasive and colonizing GBS isolates, nine of which were computationally inferred proteins (gbs2106, SAN_1577, SAN_0356, SAN_1808, SAN_1685, SAN_0413, SAN_0990, SAN_1040, SAN_0226) and one was the surface Immunogenic Protein (SIP). Additionally, the nine proteins were predicted to be more antigenic than the SIP protein (antigenicity score of > 0.6498), highlighting their potential as GBS vaccine antigen targets.

11 March 2025 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
CFCarine Bokop Fotso
Carine Bokop Fotso
NDNisha Dhar
Nisha Dhar
AIAlane Izu
Alane Izu
MAMusa Mohammed Ali
Musa Mohammed Ali
GAGodwin Akaba
Godwin Akaba
GKGaurav Kwatra
Gaurav Kwatra
To investigate the transplacental acquisition of measles IgG in newborn at delivery in Bangladesh, Bhutan, India, Ethiopia, Mozambique, Kenya, Nigeria, Mali, and South Africa. Archived cord serum, from a multi-center study on Group B Streptococcus, were tested for measles IgG using a commercial enzyme link immunosorbent assay (ELISA). We tested 323 randomly selected samples from each of the sites. Models using various measles antibody decay rates in infancy were explored. Overall, 2907 cord serum samples were analyzed. At birth, 49.9% of newborns were measles IgG seronegative. Measles seronegativity ranged from 21.7% in Nigeria to 73.4% in Bhutan. The adjusted odds of seronegativity in infants of mothers born after measles vaccination implementation was 1.78 times that for infants born to unvaccinated mothers (aOR, 1.78; 95%CI:1.43-2.21; p <0.001). Modeling measles IgG kinetics predicted 70.8%, 88.3%, and 100% of infants would be seronegative by two, four, and six months, respectively, without further exposure. Our findings suggest low transplacental acquisition of measles IgG in newborns, which is likely to yield susceptibility to measles infection at a very young age. The currently recommended measles vaccine schedules in LMIC, with the first dose recommended from nine months of age and onward, warrant reconsideration, including the need for earlier dosing schedules.

30 November 2021 in Journal of Virological Methods
Verified
Journal Article
Closed access
GKGaurav Kwatra
Gaurav Kwatra
MNMarta Nunes
Marta Nunes
NDNisha Dhar
Nisha Dhar
VBVicky Lynne Baillie
Vicky Lynne Baillie
NSNatali Serafin
Natali Serafin
SMShabir A. Madhi
Shabir A. Madhi

9 November 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
SLStephanie Leung
Stephanie Leung
CCClare Collett
Clare Collett
LALauren Allen
Lauren Allen
SLSuzanna Lim
Suzanna Lim
PMPete Maniatis
Pete Maniatis
AGAndrew GORRINGE
Andrew GORRINGE
The placental transfer of antibodies that mediate bacterial clearance via phagocytes is likely important for protection against invasive group B Streptococcus (GBS) disease. A robust functional assay is essential to determine the immune correlates of protection and assist vaccine development. Using standard reagents, we developed and optimized an opsonophagocytic killing assay (OPKA) where dilutions of test sera were incubated with bacteria, baby rabbit complement (BRC) and differentiated HL60 cells (dHL60) for 30 min. Following overnight incubation, the surviving bacteria were enumerated and the % bacterial survival was calculated relative to serum-negative controls. A reciprocal 50% killing titer was then assigned. The minimal concentrations of anti-capsular polysaccharide (CPS) IgG required for 50% killing were 1.65–3.70 ng/mL (depending on serotype). Inhibition of killing was observed using sera absorbed with homologous CPS but not heterologous CPS, indicating specificity for anti-CPS IgG. The assay performance was examined in an interlaboratory study using residual sera from CPS-conjugate vaccine trials with international partners in the Group B Streptococcus Assay STandardisatiON (GASTON) Consortium. Strong correlations of reported titers between laboratories were observed: ST-Ia r = 0.88, ST-Ib r = 0.91, ST-II r = 0.91, ST-III r = 0.90 and ST-V r = 0.94. The OPKA is an easily transferable assay with accessible standard reagents and will be a valuable tool to assess GBS-specific antibodies in natural immunity and vaccine studies.